This is a Validated Antibody Database (VAD) review about mouse NKp46, based on 108 published articles (read how Labome selects the articles), using NKp46 antibody in all methods. It is aimed to help Labome visitors find the most suited NKp46 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
NKp46 synonym: Ly94; NKp46

BioLegend
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 4e
BioLegend NKp46 antibody (BioLegend, 29A1.4) was used in flow cytometry on mouse samples (fig 4e). Front Immunol (2022) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend NKp46 antibody (Biolegend, 137621) was used in flow cytometry on mouse samples (fig 4b). Oncoimmunology (2022) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
BioLegend NKp46 antibody (Biolegend, 137607) was used in flow cytometry on mouse samples . iScience (2022) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; 1:80; loading ...; fig 6e
BioLegend NKp46 antibody (Biolegend, 137611) was used in flow cytometry on mouse samples at 1:80 (fig 6e). Proc Natl Acad Sci U S A (2022) ncbi
rat monoclonal (29A1.4)
  • immunohistochemistry; mouse; loading ...
BioLegend NKp46 antibody (Biolegend, 137612) was used in immunohistochemistry on mouse samples . Nat Commun (2021) ncbi
rat monoclonal (29A1.4)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 6a
BioLegend NKp46 antibody (BioLegend, 137601) was used in immunohistochemistry on mouse samples at 1:50 (fig 6a). Cancers (Basel) (2021) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...
BioLegend NKp46 antibody (BioLegend, 29A1.4) was used in flow cytometry on mouse samples . Front Immunol (2021) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
BioLegend NKp46 antibody (Biolegend, 137602) was used in flow cytometry on mouse samples . Cancer Cell (2021) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; 1:100; loading ...; fig s7b
BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples at 1:100 (fig s7b). Nat Commun (2021) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...
BioLegend NKp46 antibody (Biolegend, 137607) was used in flow cytometry on mouse samples . J Exp Clin Cancer Res (2021) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...
BioLegend NKp46 antibody (Biolegend, 137605) was used in flow cytometry on mouse samples . Cell Rep Med (2021) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend NKp46 antibody (Biolegend, 137608) was used in flow cytometry on mouse samples (fig s1a). JCI Insight (2021) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig s4e
BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples (fig s4e). J Immunother Cancer (2021) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend NKp46 antibody (Biolegend, 137603) was used in flow cytometry on mouse samples (fig 5c). Front Immunol (2020) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; 1:300; loading ...
BioLegend NKp46 antibody (BioLegend, 137612) was used in flow cytometry on mouse samples at 1:300. Nature (2021) ncbi
rat monoclonal (29A1.4)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig s1g
BioLegend NKp46 antibody (BioLegend, 137601) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s1g). Nat Commun (2021) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 3d
BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples (fig 3d). J Immunother Cancer (2021) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 3e
BioLegend NKp46 antibody (Biolegend, 137607) was used in flow cytometry on mouse samples (fig 3e). Theranostics (2021) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 5a
BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples (fig 5a). Antioxidants (Basel) (2020) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...
BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples . elife (2020) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig s3a, s3b, s3c, s4a
BioLegend NKp46 antibody (BioLegend, 137628) was used in flow cytometry on mouse samples (fig s3a, s3b, s3c, s4a). Cancers (Basel) (2020) ncbi
rat monoclonal (29A1.4)
  • mass cytometry; mouse; loading ...; fig 1a, 1c, s1
BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in mass cytometry on mouse samples (fig 1a, 1c, s1). Cell Rep (2019) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig s19c
BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples (fig s19c). Science (2019) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig s3j
BioLegend NKp46 antibody (BioLegend, 137623) was used in flow cytometry on mouse samples (fig s3j). Nature (2019) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples (fig 4b). Biomolecules (2019) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig s2o
BioLegend NKp46 antibody (Biolegend, 137621) was used in flow cytometry on mouse samples (fig s2o). JCI Insight (2019) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...
BioLegend NKp46 antibody (BioLegend, 29A1.4) was used in flow cytometry on mouse samples . Nature (2019) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend NKp46 antibody (BioLegend, 29A1.4) was used in flow cytometry on mouse samples (fig s2a). Science (2019) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig s2e
BioLegend NKp46 antibody (Biolegend, 137608) was used in flow cytometry on mouse samples (fig s2e). Immunity (2019) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; 1:200; loading ...; fig s4d
BioLegend NKp46 antibody (BioLegend, 137611) was used in flow cytometry on mouse samples at 1:200 (fig s4d). Nat Commun (2018) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig s3a
BioLegend NKp46 antibody (BioLegend, 29A1.4) was used in flow cytometry on mouse samples (fig s3a). J Clin Invest (2019) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend NKp46 antibody (BioLegend, 29A1.4) was used in flow cytometry on mouse samples (fig 1a). Oncoimmunology (2018) ncbi
rat monoclonal (29A1.4)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig s8b
BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig s8b). Science (2018) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; human; loading ...; fig s3a
BioLegend NKp46 antibody (BioLegend, 29A1.4) was used in flow cytometry on human samples (fig s3a). J Biol Chem (2018) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 7a
  • immunohistochemistry; mouse; loading ...; fig 2b
BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples (fig 7a) and in immunohistochemistry on mouse samples (fig 2b). Cell (2017) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig s2a, 1e
BioLegend NKp46 antibody (Biolegend, 137608) was used in flow cytometry on mouse samples (fig s2a, 1e). Sci Rep (2017) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig 2d
BioLegend NKp46 antibody (BioLegend, 137604) was used in flow cytometry on mouse samples (fig 2d). J Virol (2017) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig s10a
In order to evaluate mouse models of hepacivirus infection, BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples (fig s10a). Science (2017) ncbi
rat monoclonal (29A1.4)
  • blocking or activating experiments; mouse; fig 3a
  • flow cytometry; mouse; loading ...
In order to study the role of MCH I in natural killer cell tolerance and hyporesponsiveness, BioLegend NKp46 antibody (BioLegend, 29A1.4) was used in blocking or activating experiments on mouse samples (fig 3a) and in flow cytometry on mouse samples . J Immunol (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig s1
In order to study the functions of WASp knock out natural killer cells, BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples (fig s1). Sci Rep (2016) ncbi
rat monoclonal (29A1.4)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 7a
BioLegend NKp46 antibody (BioLegend, 29A1.4) was used in immunohistochemistry - frozen section on mouse samples (fig 7a). J Virol (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 2
BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples (fig 2). PLoS ONE (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; 1:100; fig s4
BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples at 1:100 (fig s4). Nat Commun (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig 1a
In order to report that the maternal microbiota shapes the offspring's immune system, BioLegend NKp46 antibody (Biolegend, 19A1.4) was used in flow cytometry on mouse samples (fig 1a). Science (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; 1:20; loading ...; fig 2a
In order to report the course of Rickettsia typhi infection in RAG1 knockout mice, BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples at 1:20 (fig 2a). Infect Immun (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 1d
In order to show that Bhlhe40 expression marks encephalitogenic T helper cells and that the PTX-IL-1-Bhlhe40 pathway is active in mice with experimental autoimmune encephalomyelitis, BioLegend NKp46 antibody (BioLegend, 29A1.4) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig 5
BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples (fig 5). Sci Rep (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig s5
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples (fig s5). EMBO Mol Med (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 2e
In order to assess surface expression of C-type lectin-like receptor 2 on hematopoietic cells from peripheral blood and secondary lymphoid organs, BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples (fig 2e). Eur J Immunol (2015) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig s1
In order to discuss tissue tropisms of innate lymphoid cells, BioLegend NKp46 antibody (biolegend, 29A1.4) was used in flow cytometry on mouse samples (fig s1). Immunity (2015) ncbi
rat monoclonal (29A1.4)
  • immunohistochemistry - paraffin section; mouse; tbl 1
In order to characterize histomorphometric tumors by induction of colorectal cancer in mice, BioLegend NKp46 antibody (Biolegend, 137602) was used in immunohistochemistry - paraffin section on mouse samples (tbl 1). Methods Mol Biol (2015) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
BioLegend NKp46 antibody (BioLegend, 29A1.4) was used in flow cytometry on mouse samples . J Leukoc Biol (2015) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples . Immunology (2014) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (29A1.4)
  • immunohistochemistry - paraffin section; mouse
BioLegend NKp46 antibody (Biolegend, 29A1.4) was used in immunohistochemistry - paraffin section on mouse samples . Mol Carcinog (2015) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
BioLegend NKp46 antibody (BioLegend, 29A1.4) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
In order to elucidate the immunological pathways that lead to obesity-associated asthma, BioLegend NKp46 antibody (BioLegend, 137609) was used in flow cytometry on mouse samples . Nat Med (2014) ncbi
Invitrogen
rat monoclonal (29A1.4)
  • flow cytometry; mouse; 1:50; fig 6f
Invitrogen NKp46 antibody (eBioscience, 12-3351-80) was used in flow cytometry on mouse samples at 1:50 (fig 6f). Nat Commun (2021) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; 1:100; loading ...
Invitrogen NKp46 antibody (Thermo Fisher Scientific, 29A1.4) was used in flow cytometry on mouse samples at 1:100. elife (2020) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples (fig 1d). elife (2020) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 3c
Invitrogen NKp46 antibody (Thermo Fisher, 29A1.4) was used in flow cytometry on mouse samples (fig 3c). Sci Adv (2020) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig s1i
Invitrogen NKp46 antibody (eBioscience, 25-3351-82) was used in flow cytometry on mouse samples (fig s1i). Cell Rep (2020) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; 1:200; loading ...; fig 5a
Invitrogen NKp46 antibody (eBioscience, 12-3351) was used in flow cytometry on mouse samples at 1:200 (fig 5a). Cell (2019) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig s2b
Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples (fig s2b). PLoS Pathog (2018) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; 1:100; loading ...; fig s3b
Invitrogen NKp46 antibody (eBioscience, 12-3351-82) was used in flow cytometry on mouse samples at 1:100 (fig s3b). Nat Commun (2018) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig s3d
Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples (fig s3d). Eur J Immunol (2018) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples (fig 2a). Front Immunol (2018) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 3a
In order to investigate the important of Ly49A ITIM signaling in NK-cell effector inhibition, licensing, and receptor repertoire development, Invitrogen NKp46 antibody (eBiosciences, 29A1.4) was used in flow cytometry on mouse samples (fig 3a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig 3a
In order to explore how the different Fcgamma receptors expressed on dendritic cells affect the initiation of T cell responses, Invitrogen NKp46 antibody (Thermo Fisher Scientific, 29A1.4) was used in flow cytometry on mouse samples (fig 3a). J Exp Med (2017) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig s5b
In order to demonstrate that IGF2 secreted by inhibitor of differentiation-overexpressing oesophageal cancer cells instigates VEGFR1-positive bone marrow cells in the tumor macroenvironment, Invitrogen NKp46 antibody (eBioscience, 12-3351) was used in flow cytometry on mouse samples (fig s5b). Nat Commun (2017) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; 1:100; loading ...; fig 2c
In order to find an alternative pathway of NK-cell development driven by IL-12, Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples at 1:100 (fig 2c). Nat Commun (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; 1:50
Invitrogen NKp46 antibody (eBioscience, 25-3351) was used in flow cytometry on mouse samples at 1:50. Nat Commun (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig 3
In order to study the functions of WASp knock out natural killer cells, Invitrogen NKp46 antibody (Life Technologies, 29A1.4) was used in flow cytometry on mouse samples (fig 3). Sci Rep (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples (fig 4a). J Immunol (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig 1b
Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples (fig 1b). Immunity (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
In order to analyze inhibition of IL-17-mediated colon inflammation and tumorigenesis by ROR-gamma-t ubiquitination by Itch, Invitrogen NKp46 antibody (eBioscience, 11-3351-82) was used in flow cytometry on mouse samples . Nat Immunol (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig 5
Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples (fig 5). Sci Rep (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; 1:100; fig s4
In order to assess the role of NLRC5 to NK-T-cell crosstalk, Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples at 1:100 (fig s4). Nat Commun (2016) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; 1:1000; fig s8
In order to test if GATA5 is a regulator of blood pressure, Invitrogen NKp46 antibody (eBioscience, 48-3351-82) was used in flow cytometry on mouse samples at 1:1000 (fig s8). Nat Commun (2015) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
In order to propose that IL-17-producing gammadelta T cells help to maintain and protect the intestinal mucosa, Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples . Immunity (2015) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 5a
Invitrogen NKp46 antibody (Affymetrix/eBioscience, 29A1.4) was used in flow cytometry on mouse samples (fig 5a). Oncoimmunology (2015) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig s1
In order to maintain intestinal epithelial cells after tissue damage via type 3 innate lymphoid cells, Invitrogen NKp46 antibody (eBioscience, 2941.4) was used in flow cytometry on mouse samples (fig s1). J Exp Med (2015) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig 5
Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples (fig 5). Nat Immunol (2015) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
In order to characterize high zone tolerance in mouse models of type I allergy and of allergic airway inflammation, Invitrogen NKp46 antibody (eBioscience, clone 29A1.4) was used in flow cytometry on mouse samples . Immunobiology (2015) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples . PLoS Pathog (2014) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig 5a
In order to report the development of dendritic cells and other lineages in Bcl11a knockout mice, Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples (fig 5a). PLoS ONE (2013) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
In order to examine IL-7R signaling in Tbx21 and Rag2 knockout mice, Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples . Immunity (2012) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig 3
Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples (fig 3). Nat Immunol (2011) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples . Blood (2010) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
Invitrogen NKp46 antibody (eBioscience, 29A1.4) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
Miltenyi Biotec
rat monoclonal (29A1.4.9)
  • flow cytometry; mouse; loading ...; fig s6
Miltenyi Biotec NKp46 antibody (Miltenyi Biotec, 130-102-185) was used in flow cytometry on mouse samples (fig s6). Cell (2019) ncbi
rat monoclonal (29A1.4.9)
  • flow cytometry; mouse; loading ...; fig 3b
Miltenyi Biotec NKp46 antibody (Miltenyi Biotec, 29A1.4.9) was used in flow cytometry on mouse samples (fig 3b). J Transl Med (2017) ncbi
rat monoclonal (29A1.4.9)
  • flow cytometry; mouse; 1:100; loading ...; fig 6b
In order to find genes that alter invariant natural killer T cell development, migration, or function, Miltenyi Biotec NKp46 antibody (Miltenyi Biotec, 29A1.4.9) was used in flow cytometry on mouse samples at 1:100 (fig 6b). Nat Commun (2016) ncbi
R&D Systems
domestic goat polyclonal
  • immunohistochemistry; mouse; loading ...; fig 4d
R&D Systems NKp46 antibody (R&D System, AF2225) was used in immunohistochemistry on mouse samples (fig 4d). Nat Commun (2021) ncbi
BD Biosciences
rat monoclonal (29A1.4)
  • flow cytometry; mouse; 1:200; loading ...; fig e8b
BD Biosciences NKp46 antibody (BD Pharmingen, 29A1.4) was used in flow cytometry on mouse samples at 1:200 (fig e8b). Nature (2019) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig s6d
BD Biosciences NKp46 antibody (BD Biosciences, 29A1.4) was used in flow cytometry on mouse samples (fig s6d). Science (2018) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig 3c
BD Biosciences NKp46 antibody (BD Biosciences, 29A1.4) was used in flow cytometry on mouse samples (fig 3c). Oncotarget (2018) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 2c
BD Biosciences NKp46 antibody (BD Pharmingen, 29A1.4) was used in flow cytometry on mouse samples (fig 2c). Int J Cancer (2018) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 1a
BD Biosciences NKp46 antibody (BD Bioscience, 560756) was used in flow cytometry on mouse samples (fig 1a). PLoS Biol (2018) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; loading ...; fig 3d
In order to investigate the ability of PTEN to regulate natural killer cell function, BD Biosciences NKp46 antibody (BD Biosciences, 29A1.4) was used in flow cytometry on mouse samples (fig 3d). J Immunol (2015) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
BD Biosciences NKp46 antibody (BD Biosciences, 29A1.4) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
BD Biosciences NKp46 antibody (BD Pharmingen, 29A1.4) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
BD Biosciences NKp46 antibody (BD Pharmigen, 560800) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (29A1.4)
  • immunohistochemistry; mouse; 1:500
BD Biosciences NKp46 antibody (BD Pharmigen, 560754) was used in immunohistochemistry on mouse samples at 1:500. Cancer Res (2014) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse; fig 4
BD Biosciences NKp46 antibody (BD Biosciences, 29A1.4) was used in flow cytometry on mouse samples (fig 4). Mucosal Immunol (2014) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
BD Biosciences NKp46 antibody (BD Biosciences, 29A1.4) was used in flow cytometry on mouse samples . Mucosal Immunol (2014) ncbi
rat monoclonal (29A1.4)
  • flow cytometry; mouse
BD Biosciences NKp46 antibody (BD Biosciences, 29A1.4) was used in flow cytometry on mouse samples . J Immunol (2013) ncbi
Articles Reviewed
  1. Shi Z, Takeuchi T, Nakanishi Y, Kato T, Beck K, Nagata R, et al. A Japanese Herbal Formula, Daikenchuto, Alleviates Experimental Colitis by Reshaping Microbial Profiles and Enhancing Group 3 Innate Lymphoid Cells. Front Immunol. 2022;13:903459 pubmed publisher
  2. Melese E, Franks E, Cederberg R, Harbourne B, Shi R, Wadsworth B, et al. CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development. Oncoimmunology. 2022;11:2010905 pubmed publisher
  3. Sibilio A, Suñer C, Fernández Alfara M, Martín J, Berenguer A, Calon A, et al. Immune translational control by CPEB4 regulates intestinal inflammation resolution and colorectal cancer development. iScience. 2022;25:103790 pubmed publisher
  4. Wolpaw A, Grossmann L, Dessau J, Dong M, Aaron B, Brafford P, et al. Epigenetic state determines inflammatory sensing in neuroblastoma. Proc Natl Acad Sci U S A. 2022;119: pubmed publisher
  5. Xu B, Tian L, Chen J, Wang J, Ma R, Dong W, et al. An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma. Nat Commun. 2021;12:5908 pubmed publisher
  6. Van Maldegem F, Valand K, Cole M, Patel H, Angelova M, Rana S, et al. Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry. Nat Commun. 2021;12:5906 pubmed publisher
  7. Drzyzga A, Cichon T, Czapla J, Jarosz Biej M, Pilny E, Matuszczak S, et al. The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent-DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors. Cancers (Basel). 2021;13: pubmed publisher
  8. Mathä L, Romera Hernandez M, Steer C, Yin Y, Orangi M, Shim H, et al. Migration of Lung Resident Group 2 Innate Lymphoid Cells Link Allergic Lung Inflammation and Liver Immunity. Front Immunol. 2021;12:679509 pubmed publisher
  9. Hutton C, Heider F, Blanco Gómez A, Banyard A, Kononov A, Zhang X, et al. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity. Cancer Cell. 2021;: pubmed publisher
  10. Lin Q, Rong L, Jia X, Li R, Yu B, Hu J, et al. IFN-γ-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella. Nat Commun. 2021;12:2537 pubmed publisher
  11. Ercolano G, Gomez Cadena A, Dumauthioz N, Vanoni G, Kreutzfeldt M, Wyss T, et al. PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions. Nat Commun. 2021;12:2538 pubmed publisher
  12. Sánchez del Campo L, Martí Díaz R, Montenegro M, González Guerrero R, Hernández Caselles T, Martínez Barba E, et al. MITF induces escape from innate immunity in melanoma. J Exp Clin Cancer Res. 2021;40:117 pubmed publisher
  13. Bonilla W, Kirchhammer N, Marx A, Kallert S, Krzyzaniak M, Lu M, et al. Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack. Cell Rep Med. 2021;2:100209 pubmed publisher
  14. Xiao Y, Shu L, Wu X, Liu Y, Cheong L, Liao B, et al. Fatty acid binding protein 4 promotes autoimmune diabetes by recruitment and activation of pancreatic islet macrophages. JCI Insight. 2021;6: pubmed publisher
  15. Can xe8 S, Van Snick J, Uyttenhove C, Pilotte L, van den Eynde B. TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism. J Immunother Cancer. 2021;9: pubmed publisher
  16. Guo S, Smeltz R, Nanajian A, Heller R. IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models. Front Immunol. 2020;11:614667 pubmed publisher
  17. Bielecki P, Riesenfeld S, Hütter J, Torlai Triglia E, Kowalczyk M, Ricardo Gonzalez R, et al. Skin-resident innate lymphoid cells converge on a pathogenic effector state. Nature. 2021;592:128-132 pubmed publisher
  18. Tyagi A, Sharma S, Wu K, Wu S, Xing F, Liu Y, et al. Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung. Nat Commun. 2021;12:474 pubmed publisher
  19. Brownlie D, Doughty Shenton D, Yh Soong D, Nixon C, O Carragher N, M Carlin L, et al. Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β. J Immunother Cancer. 2021;9: pubmed publisher
  20. Chen W, Wu Y, Tsai T, Li R, Lai A, Li L, et al. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis. Theranostics. 2021;11:2594-2611 pubmed publisher
  21. Meryk A, Grasse M, Balasco L, Kapferer W, Grubeck Loebenstein B, Pangrazzi L. Antioxidants N-Acetylcysteine and Vitamin C Improve T Cell Commitment to Memory and Long-Term Maintenance of Immunological Memory in Old Mice. Antioxidants (Basel). 2020;9: pubmed publisher
  22. Lissner M, Cumnock K, Davis N, Vilches Moure J, Basak P, Navarrete D, et al. Metabolic profiling during malaria reveals the role of the aryl hydrocarbon receptor in regulating kidney injury. elife. 2020;9: pubmed publisher
  23. Piersma S, Poursine Laurent J, Yang L, Barber G, Parikh B, Yokoyama W. Virus infection is controlled by hematopoietic and stromal cell sensing of murine cytomegalovirus through STING. elife. 2020;9: pubmed publisher
  24. Tizian C, Lahmann A, Hölsken O, Cosovanu C, Kofoed Branzk M, Heinrich F, et al. c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells. elife. 2020;9: pubmed publisher
  25. Cohen G, Chandran P, Lorsung R, Tomlinson L, Sundby M, Burks S, et al. The Impact of Focused Ultrasound in Two Tumor Models: Temporal Alterations in the Natural History on Tumor Microenvironment and Immune Cell Response. Cancers (Basel). 2020;12: pubmed publisher
  26. Park M, Kim H, Lee H, Zabel B, Bae Y. Novel CD11b+Gr-1+Sca-1+ myeloid cells drive mortality in bacterial infection. Sci Adv. 2020;6:eaax8820 pubmed publisher
  27. Blagih J, Zani F, Chakravarty P, Hennequart M, Pilley S, Hobor S, et al. Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses. Cell Rep. 2020;30:481-496.e6 pubmed publisher
  28. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  29. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed publisher
  30. Benechet A, De Simone G, Di Lucia P, Cilenti F, Barbiera G, Le Bert N, et al. Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming. Nature. 2019;574:200-205 pubmed publisher
  31. Lecocq Q, Zeven K, De Vlaeminck Y, Martens S, Massa S, Goyvaerts C, et al. Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use. Biomolecules. 2019;9: pubmed publisher
  32. Wirsching H, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino P, et al. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. JCI Insight. 2019;4: pubmed publisher
  33. Gauthier L, Morel A, Anceriz N, Rossi B, Blanchard Alvarez A, Grondin G, et al. Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity. Cell. 2019;177:1701-1713.e16 pubmed publisher
  34. Di Pilato M, Kim E, Cadilha B, Prüßmann J, Nasrallah M, Seruggia D, et al. Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy. Nature. 2019;570:112-116 pubmed publisher
  35. Jacome Galarza C, Percin G, Muller J, Mass E, Lazarov T, Eitler J, et al. Developmental origin, functional maintenance and genetic rescue of osteoclasts. Nature. 2019;568:541-545 pubmed publisher
  36. Davies A, Kim H, González Cano R, Choi J, Back S, Roh S, et al. Natural Killer Cells Degenerate Intact Sensory Afferents following Nerve Injury. Cell. 2019;176:716-728.e18 pubmed publisher
  37. Martins J, Andoniou C, Fleming P, Kuns R, Schuster I, Voigt V, et al. Strain-specific antibody therapy prevents cytomegalovirus reactivation after transplantation. Science. 2019;363:288-293 pubmed publisher
  38. Britton G, Contijoch E, Mogno I, Vennaro O, Llewellyn S, Ng R, et al. Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice. Immunity. 2019;50:212-224.e4 pubmed publisher
  39. Ruscetti M, Leibold J, Bott M, Fennell M, Kulick A, Salgado N, et al. NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science. 2018;362:1416-1422 pubmed publisher
  40. Jensen I, Winborn C, Fosdick M, Shao P, Tremblay M, Shan Q, et al. Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections. PLoS Pathog. 2018;14:e1007405 pubmed publisher
  41. Sheng C, Yao C, Wang Z, Chen H, Zhao Y, Xu D, et al. Cyclophilin J limits inflammation through the blockage of ubiquitin chain sensing. Nat Commun. 2018;9:4381 pubmed publisher
  42. Abreu Mota T, Hagen K, Cooper K, Jahrling P, Tan G, Wirblich C, et al. Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever. Nat Commun. 2018;9:4223 pubmed publisher
  43. Vuckovic S, Minnie S, Smith D, Gartlan K, Watkins T, Markey K, et al. Bone marrow transplantation generates T cell-dependent control of myeloma in mice. J Clin Invest. 2019;129:106-121 pubmed publisher
  44. Almeida F, Tognarelli S, Marcais A, Kueh A, Friede M, Liao Y, et al. A point mutation in the Ncr1 signal peptide impairs the development of innate lymphoid cell subsets. Oncoimmunology. 2018;7:e1475875 pubmed publisher
  45. Amôr N, de Oliveira C, Gasparoto T, Vilas Boas V, Perri G, Kaneno R, et al. ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate. Oncotarget. 2018;9:30894-30904 pubmed publisher
  46. Baens M, Stirparo R, Lampi Y, Verbeke D, Vandepoel R, Cools J, et al. Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice. Eur J Immunol. 2018;48:1728-1738 pubmed publisher
  47. Abel A, Tiwari A, Gerbec Z, Siebert J, Yang C, Schloemer N, et al. IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells. Front Immunol. 2018;9:1168 pubmed publisher
  48. Pommier A, Anaparthy N, Memos N, Kelley Z, Gouronnec A, Yan R, et al. Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases. Science. 2018;360: pubmed publisher
  49. Stefani F, Eberstål S, Vergani S, Kristiansen T, Bengzon J. Low-dose irradiated mesenchymal stromal cells break tumor defensive properties in vivo. Int J Cancer. 2018;143:2200-2212 pubmed publisher
  50. Wang Y, Dong W, Zhang Y, Caligiuri M, Yu J. Dependence of innate lymphoid cell 1 development on NKp46. PLoS Biol. 2018;16:e2004867 pubmed publisher
  51. Cribbs A, Hookway E, Wells G, Lindow M, Obad S, Oerum H, et al. Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells. J Biol Chem. 2018;293:2422-2437 pubmed publisher
  52. Kortlever R, Sodir N, Wilson C, Burkhart D, Pellegrinet L, Brown Swigart L, et al. Myc Cooperates with Ras by Programming Inflammation and Immune Suppression. Cell. 2017;171:1301-1315.e14 pubmed publisher
  53. Glasner A, Isaacson B, Viukov S, Neuman T, Friedman N, Mandelboim M, et al. Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression. Sci Rep. 2017;7:13090 pubmed publisher
  54. Bern M, Beckman D, Ebihara T, Taffner S, Poursine Laurent J, White J, et al. Immunoreceptor tyrosine-based inhibitory motif-dependent functions of an MHC class I-specific NK cell receptor. Proc Natl Acad Sci U S A. 2017;114:E8440-E8447 pubmed publisher
  55. Bar On Y, Charpak Amikam Y, Glasner A, Isaacson B, Duev Cohen A, Tsukerman P, et al. NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy. J Virol. 2017;91: pubmed publisher
  56. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  57. Escribà Garcia L, Alvarez Fernández C, Tellez Gabriel M, Sierra J, Briones J. Dendritic cells combined with tumor cells and ?-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma. J Transl Med. 2017;15:115 pubmed publisher
  58. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed publisher
  59. Xu W, Li B, Guan X, Chung S, Wang Y, Yip Y, et al. Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression. Nat Commun. 2017;8:14399 pubmed publisher
  60. Ohs I, Van Den Broek M, Nussbaum K, MUNZ C, Arnold S, Quezada S, et al. Interleukin-12 bypasses common gamma-chain signalling in emergency natural killer cell lymphopoiesis. Nat Commun. 2016;7:13708 pubmed publisher
  61. Shifrin N, Kissiov D, Ardolino M, Joncker N, Raulet D. Differential Role of Hematopoietic and Nonhematopoietic Cell Types in the Regulation of NK Cell Tolerance and Responsiveness. J Immunol. 2016;197:4127-4136 pubmed publisher
  62. Georgiev H, Ravens I, Benarafa C, Forster R, Bernhardt G. Distinct gene expression patterns correlate with developmental and functional traits of iNKT subsets. Nat Commun. 2016;7:13116 pubmed publisher
  63. Klose R, Krzywinska E, Castells M, Gotthardt D, Putz E, Kantari Mimoun C, et al. Targeting VEGF-A in myeloid cells enhances natural killer cell responses to chemotherapy and ameliorates cachexia. Nat Commun. 2016;7:12528 pubmed publisher
  64. Kritikou J, Dahlberg C, Baptista M, Wagner A, Banerjee P, Gwalani L, et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep. 2016;6:30636 pubmed publisher
  65. Chow K, Delconte R, Huntington N, Tarlinton D, Sutherland R, Zhan Y, et al. Innate Allorecognition Results in Rapid Accumulation of Monocyte-Derived Dendritic Cells. J Immunol. 2016;197:2000-8 pubmed publisher
  66. Lawler C, Tan C, Simas J, Stevenson P. Type I Interferons and NK Cells Restrict Gammaherpesvirus Lymph Node Infection. J Virol. 2016;90:9046-57 pubmed publisher
  67. Wang S, Xia P, Chen Y, Huang G, Xiong Z, Liu J, et al. Natural Killer-like B Cells Prime Innate Lymphocytes against Microbial Infection. Immunity. 2016;45:131-44 pubmed publisher
  68. Kathania M, Khare P, Zeng M, Cantarel B, Zhang H, Ueno H, et al. Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-?t ubiquitination. Nat Immunol. 2016;17:997-1004 pubmed publisher
  69. Brandstätter O, Schanz O, Vorac J, König J, Mori T, Maruyama T, et al. Balancing intestinal and systemic inflammation through cell type-specific expression of the aryl hydrocarbon receptor repressor. Sci Rep. 2016;6:26091 pubmed publisher
  70. Qualai J, Li L, Cantero J, Tarrats A, Fernández M, Sumoy L, et al. Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential. PLoS ONE. 2016;11:e0154253 pubmed publisher
  71. Li Z, Hodgkinson T, Gothard E, Boroumand S, Lamb R, Cummins I, et al. Epidermal Notch1 recruits RORγ(+) group 3 innate lymphoid cells to orchestrate normal skin repair. Nat Commun. 2016;7:11394 pubmed publisher
  72. Gomez de Agüero M, Ganal Vonarburg S, Fuhrer T, Rupp S, Uchimura Y, Li H, et al. The maternal microbiota drives early postnatal innate immune development. Science. 2016;351:1296-302 pubmed publisher
  73. Osterloh A, Papp S, Moderzynski K, Kuehl S, Richardt U, Fleischer B. Persisting Rickettsia typhi Causes Fatal Central Nervous System Inflammation. Infect Immun. 2016;84:1615-1632 pubmed publisher
  74. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  75. Lin C, Bradstreet T, Schwarzkopf E, Jarjour N, Chou C, Archambault A, et al. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J Exp Med. 2016;213:251-71 pubmed publisher
  76. Polansky J, Bahri R, Divivier M, Duitman E, Vock C, Goyeneche Patino D, et al. High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner. Sci Rep. 2016;6:19699 pubmed publisher
  77. Catarinella M, Monestiroli A, Escobar G, Fiocchi A, Tran N, Aiolfi R, et al. IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment. EMBO Mol Med. 2016;8:155-70 pubmed publisher
  78. Messaoudi S, He Y, Gutsol A, Wight A, Hébert R, Vilmundarson R, et al. Endothelial Gata5 transcription factor regulates blood pressure. Nat Commun. 2015;6:8835 pubmed publisher
  79. Lee J, Tato C, Joyce Shaikh B, Gulen M, Gulan F, Cayatte C, et al. Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability. Immunity. 2015;43:727-38 pubmed publisher
  80. Wilson K, Goding S, Neely H, Harris K, Antony P. Depletion of B220+NK1.1+ cells enhances the rejection of established melanoma by tumor-specific CD4+ T cells. Oncoimmunology. 2015;4:e1019196 pubmed
  81. Aparicio Domingo P, Romera Hernandez M, Karrich J, Cornelissen F, Papazian N, Lindenbergh Kortleve D, et al. Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage. J Exp Med. 2015;212:1783-91 pubmed publisher
  82. Lowe K, Navarro Núñez L, Bénézech C, Nayar S, Kingston B, Nieswandt B, et al. The expression of mouse CLEC-2 on leucocyte subsets varies according to their anatomical location and inflammatory state. Eur J Immunol. 2015;45:2484-93 pubmed publisher
  83. Kim M, Taparowsky E, Kim C. Retinoic Acid Differentially Regulates the Migration of Innate Lymphoid Cell Subsets to the Gut. Immunity. 2015;43:107-19 pubmed publisher
  84. Wensveen F, Jelenčić V, Valentić S, Šestan M, Wensveen T, Theurich S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16:376-85 pubmed publisher
  85. Crncec I, Pathria P, Svinka J, Eferl R. Induction of colorectal cancer in mice and histomorphometric evaluation of tumors. Methods Mol Biol. 2015;1267:145-64 pubmed publisher
  86. Briercheck E, Trotta R, Chen L, Hartlage A, Cole J, Cole T, et al. PTEN is a negative regulator of NK cell cytolytic function. J Immunol. 2015;194:1832-40 pubmed publisher
  87. Spada R, Rojas J, Pérez Yagüe S, Mulens V, Cannata Ortiz P, Bragado R, et al. NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery. J Leukoc Biol. 2015;97:583-98 pubmed publisher
  88. Raker V, Stein J, Montermann E, Maxeiner J, Taube C, Reske Kunz A, et al. Regulation of IgE production and airway reactivity by CD4⁻CD8⁻ regulatory T cells. Immunobiology. 2015;220:490-9 pubmed publisher
  89. Dang V, Tanabe K, Tanaka Y, Tokumoto N, Misumi T, Saeki Y, et al. Fasting enhances TRAIL-mediated liver natural killer cell activity via HSP70 upregulation. PLoS ONE. 2014;9:e110748 pubmed publisher
  90. Guttman O, Yossef R, Freixo Lima G, Rider P, Porgador A, Lewis E. α1-Antitrypsin modifies general NK cell interactions with dendritic cells and specific interactions with islet β-cells in favor of protection from autoimmune diabetes. Immunology. 2014;: pubmed publisher
  91. Wei H, Nash W, Makrigiannis A, Brown M. Impaired NK-cell education diminishes resistance to murine CMV infection. Eur J Immunol. 2014;44:3273-82 pubmed publisher
  92. Pisano F, Heine W, Rosenheinrich M, Schweer J, Nuss A, Dersch P. Influence of PhoP and intra-species variations on virulence of Yersinia pseudotuberculosis during the natural oral infection route. PLoS ONE. 2014;9:e103541 pubmed publisher
  93. Larsen J, Dall M, Antvorskov J, Weile C, Engkilde K, Josefsen K, et al. Dietary gluten increases natural killer cell cytotoxicity and cytokine secretion. Eur J Immunol. 2014;44:3056-67 pubmed publisher
  94. Baker G, Chockley P, Yadav V, Doherty R, Ritt M, Sivaramakrishnan S, et al. Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity. Cancer Res. 2014;74:5079-90 pubmed publisher
  95. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed publisher
  96. Janakiram N, Mohammed A, Bryant T, Brewer M, Biddick L, Lightfoot S, et al. Adoptive transfer of regulatory T cells promotes intestinal tumorigenesis and is associated with decreased NK cells and IL-22 binding protein. Mol Carcinog. 2015;54:986-98 pubmed publisher
  97. Ebert S, Becker M, Lemmermann N, Büttner J, Michel A, Taube C, et al. Mast cells expedite control of pulmonary murine cytomegalovirus infection by enhancing the recruitment of protective CD8 T cells to the lungs. PLoS Pathog. 2014;10:e1004100 pubmed publisher
  98. Chognard G, Bellemare L, Pelletier A, Domínguez Punaro M, Beauchamp C, Guyon M, et al. The dichotomous pattern of IL-12r and IL-23R expression elucidates the role of IL-12 and IL-23 in inflammation. PLoS ONE. 2014;9:e89092 pubmed publisher
  99. Jayaraman A, Jackson D, Message S, Pearson R, Aniscenko J, Caramori G, et al. IL-15 complexes induce NK- and T-cell responses independent of type I IFN signaling during rhinovirus infection. Mucosal Immunol. 2014;7:1151-64 pubmed publisher
  100. Wickström S, Oberg L, Kärre K, Johansson M. A genetic defect in mice that impairs missing self recognition despite evidence for normal maturation and MHC class I-dependent education of NK cells. J Immunol. 2014;192:1577-86 pubmed publisher
  101. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed publisher
  102. Chan I, Jain R, Tessmer M, Gorman D, Mangadu R, Sathe M, et al. Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. Mucosal Immunol. 2014;7:842-56 pubmed publisher
  103. Pierini R, Perret M, Djebali S, Juruj C, Michallet M, Forster I, et al. ASC controls IFN-? levels in an IL-18-dependent manner in caspase-1-deficient mice infected with Francisella novicida. J Immunol. 2013;191:3847-57 pubmed publisher
  104. Wu X, Satpathy A, Kc W, Liu P, Murphy T, Murphy K. Bcl11a controls Flt3 expression in early hematopoietic progenitors and is required for pDC development in vivo. PLoS ONE. 2013;8:e64800 pubmed publisher
  105. Powell N, Walker A, Stolarczyk E, Canavan J, Gökmen M, Marks E, et al. The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity. 2012;37:674-84 pubmed publisher
  106. Ota N, Wong K, Valdez P, Zheng Y, Crellin N, Diehl L, et al. IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nat Immunol. 2011;12:941-8 pubmed publisher
  107. White D, Keppel C, Schneider S, Reese T, Coder J, Payton J, et al. Latent herpesvirus infection arms NK cells. Blood. 2010;115:4377-83 pubmed publisher
  108. Cai S, Fehniger T, Cao X, Mayer J, Brune J, French A, et al. Differential expression of granzyme B and C in murine cytotoxic lymphocytes. J Immunol. 2009;182:6287-97 pubmed publisher